4078 J . Org. Chem., Vol. 61, No. 12, 1996
Searle et al.
was purified by column chromatography (silica gel, CHCl3/
MeOH 99:1) to afford the C10 alcohol 5 as a colorless oil (8.1
mg, 87%): IR (film) νmax 3500-3100 cm-1; 1H NMR (CDCl3) δ
1.34 (d, J ) 6.1 Hz, 3H), 1.36 (s, 3H), 1.40 (s, 3H), 1.43 (s,
3H), 1.54 (s, 3H), 1.69 (ddd, J ) 13.0, 11.8, 11.4 Hz, 1H), 2.10
(ddd, J ) 13.0, 2.5, 2.1 Hz, 1H), 3.44 (dd, J ) 7.6, 7.2 Hz, 1H),
3.86 (br d, J ) 5.8 Hz, 1H), 3.94 (ddd, J ) 11.4, 7.2, 2.5 Hz,
1H), 4.00 (dq, J ) 7.6, 6.1 Hz, 1H), 4.97 (dd, J ) 11.8, 2.1 Hz,
1H), 5.98 (d, J ) 5.8 Hz, 1H), 7.13 (s, 1H), 7.60 (s, 1H), 7.88
(s, 1H); 13C NMR (CDCl3) δ 19.3 (q), 19.7 (q), 26.9 (q), 27.4 (q),
29.8 (q), 33.6 (t), 62.3 (d), 65.1 (d), 71.0 (d), 76.3 (d), 84.1 (d),
99.1 (s), 108.7 (s), 125.1 (d), 136.1 (d), 142.3 (s), 149.0 (s), 151.5
(d), 161.2 (s); FABMS m/z 395 (MH+, 58%), 379 (M+ - CH3,
10), 337 (45), 279 (100), 261 (30); HRFABMS found 395.1800
(MH+), C19H27N2O7 requires 395.1818.
as described previously.32 Purification of each crude product
by chromatography (basic alumina, 1:5 to 1:1 EtOAc/n-hexane)
gave (R)-MTPA ester 9a (65%) and (S)-MTPA ester 9b (46%,
see Figure 2 for 1H NMR ∆δ18). Ester 9a : HRFABMS found
(MH+) 611.2214, calculated for C29H33N2O9F3 611.2216. Ester
9b : HRFABMS found (MH+) 611.2229, calculated for
C29H33N2O9F3 611.2216.
Ben ga zole Tetr a -p-bromobenzoate (10). The mixture of
bengazoles A-G (1a-g, 2.0 mg) was converted to their
corresponding tetra-O-p-bromobenzoates as described above
for 8. Purification of the crude product by chromatography
(silica gel, 75:25 n-hexane/EtOAc) gave tetra-O-p-bromoben-
zoate 10 as a mixture of fatty acid esters at O-C10 (1.2 mg,
∼25%) and as a colorless glass: CD (MeCN) 252 (∆ꢀ -14.6),
246 (0), 235 (+17.4), 219 (+3.2), 208 (12.8), 200 (0), 197 (-9.8).
(1R,3S,4R,5R)1-P h en ylh exa n e-1,3,4,5-tetr ol Tetr a -O-p-
br om oben zoa te (11). A solution of the tetrol 2 (5.0 mg, 0.022
mmol) in pyridine (3 mL) was treated with p-bromobenzoyl
chloride (80 mg, 0.36 mmol) and 4-(N,N-dimethylamino)-
pyridine (ca. 0.1 mg). After 18 h of stirring at 25 °C, 3-(N,N-
dimethylamino)propylamine (800 µL) was added and stirring
continued for a further 30 min. Pyridine was removed under
high vacuum, and the residue was chromatographed on silica
gel (hexane/EtOAc 9:1) to afford the tetra-p-bromobenzoate 11
as a colorless glass (19.2 mg, 91%): UV (MeCN) λmax 244 nm
(ꢀ 70100); CD (MeCN) λ 252 (∆ꢀ +6.5), 244 (0), 234 (-19.5),
207 (-9.8), 200 (0), 197 (+2.5); IR (film) νmax 1710, 1590, 1266,
1099, 1011, 753 cm-1; 1H NMR (CDCl3) δ 1.28 (d, J ) 6.5 Hz,
3H), 2.42 (ddd, J ) 14.6, 7.4, 2.6 Hz, 1H), 2.71 (ddd, J ) 14.6,
9.6, 6.4 Hz, 1H), 5.43 (m, 2H), 5.62 (dd, J ) 5.3, 4.8 Hz, 1H),
6.09 (dd, J ) 7.4, 6.4 Hz, 1H), 7.24-7.34 (m, 5H), 7.46 (d, J )
8.5 Hz, 2H), 7.47 (d, J ) 8.5 Hz, 2H), 7.48 (d, J ) 8.5 Hz, 2H),
7.58 (d, J ) 8.5 Hz, 2H), 7.65 (d, J ) 8.5 Hz, 2H), 7.71 (d, J )
8.5 Hz, 2H), 7.79 (d, J ) 8.5 Hz, 2H), 7.84 (d, J ) 8.5 Hz, 2H);
HRFABMS found 954.8815 (MH+), C40H31O8Br4 requires
954.8752.
Ben zyl L-F u cop yr a n osid e (12) a n d Ben zyl 3,4-Isop r o-
p ylid en e-L-fu cop yr a n osid e (13). A stirred suspension of
L-fucose (2.00 g, 12.2 mmol) in benzyl alcohol (10 mL) was
saturated with dry HCl gas (∼10 min), stirred for 3 h at 25
°C, and then allowed to stand at 4 °C for 16 h. The volatiles
were removed under vacuum, and the residue was purified
by column chromatography (silica gel, MeOH/CHCl3 1:19 to
1:9) to provide pure 1-O-benzyl-L-fucose (12, 2.48 g, 80%) as a
viscous oil (5/1 mixture of â/R anomers, by 1H NMR) which
was used directly in the next step. Benzyl glycoside 12 was
suspended in acetone (20 mL) and 2,2-dimethoxypropane (30
mL) and stirred with a catalytic amount of p-TSA. The
mixture produced a homogeneous solution after 15 min. After
1.5 h, the mixture was concentrated and the residue was
purified by chromatography (silica gel, ethyl acetate/hexane
1:1 ) to give 1-O-benzyl acetonide 13 as a viscous colorless oil
(2.78, 97%) that was used directly in the next step.
Ben ga zole Aceton id e 10-O-p-Br om oben zoa te (6).
A
solution of 5 (7.9 mg) in pyridine (1.5 mL) was treated with
p-bromobenzoyl chloride (100 µL) and DMAP (ca. 0.1 mg), and
the solution was heated at 50 °C for 2 h. Pyridine was
removed under high vacuum, and the residue was purified by
preparative TLC (silica gel, 1 mm, CHCl3/MeOH 96.5:3.5) to
afford the p-bromobenzoyl derivative 6 as a colorless solid (8.2
1
mg, 71%): IR (film) νmax 1735 cm-1; H NMR (CDCl3) δ 1.33
(d, J ) 6.0 Hz, 3H), 1.36 (s, 3H), 1.40 (s, 3H), 1.43 (s, 3H),
1.53 (s, 3H), 1.65 (ddd, J ) 13.0, 11.4, 11.3 Hz, 1H), 2.13 (dt,
J ) 13.0, 2.5 Hz, 1H), 3.44 (t, J ) 7.4 Hz, 1H), 3.94 (ddd, J )
11.4, 7.1, 2.5 Hz, 1H), 4.00 (dq, 7.4, 6.0 Hz, 1H), 4.99 (dd, J )
11.3, 2.5 Hz, 1H), 7.30 (s, 1H), 7.32 (s, 1H), 7.60 (d, J ) 8.7
Hz, 2H), 7.65 (s, 1H), 7.93 (d, J ) 8.7 Hz, 2H), 7.93 (s, 1H);
FABMS m/ z 579 (MH+ + 2, 14%), 577 (MH+, 13), 521 (18),
519 (20), 463 (30), 461 (32), 185 (95), 183 (100); HRFABMS
found 577.1188 (MH+), C26H30N2O8Br requires 577.1186.
Ben ga zole Tetr ol 10-O-p-Br om oben zoa te (7). A solu-
tion of 6 in THF (1.0 mL) was treated with 50% aqueous acetic
acid (1.6 mL) and heated to 60 °C under a nitrogen atmosphere
for 19 h. The solution was evaporated to dryness under
reduced pressure, and the residue was purified by column
chromatography (silica gel, CHCl3/MeOH 9:1) to afford the
p-bromobenzoyl derivative 7 as a colorless solid (3.6 mg,
69%): IR (film) νmax 3600-3100, 1730 cm-1 1H NMR (CD3-
;
OD) δ 1.11 (d, J ) 6.6 Hz, 3H), 1.90 (ddd, J ) 14.0, 9.7, 6.8
Hz, 1H), 2.23 (ddd, J ) 14.0, 7.2, 2.7 Hz, 1H), 3.16 (dd, J )
6.7, 3.4 Hz, 1H), 3.65 (ddd, J ) 9.7, 6.7, 2.7 Hz, 1H), 3.89 (qd,
J ) 6.6, 3.4 Hz, 1H), 4.92 (dd, 7.2, 6.8 Hz, 1H), 7.35 (s, 1H),
7.41 (s, 1H), 7.69 (d, J ) 8.7 Hz, 2H), 7.88 (s, 1H), 7.95 (d, J
) 8.7 Hz, 2H), 8.29 (s, 1H); FABMS m/ z 499 (MH+ + 2, 41%),
497 (MH+, 42); HRFABMS found 497.0560 (MH+), C20H22N2O8-
Br requires 497.0559.
Ben ga zole P en ta -p-br om oben zoa te (8). A solution of 3
(5.3 mg) in pyridine (2.0 mL) was treated with p-bromobenzoyl
chloride (ca. 16 mg) and DMAP (ca. 0.1 mg), and the solution
was heated at 55 °C for 20 h. Excess p-bromobenzoyl chloride
was quenched by the addition of 3-(N,N-dimethylamino)-
propylamine (50 µL), and the reaction mixture was stirred for
an additional 1 h. Pyridine was removed under high vacuum,
and the residue was purified by column chromatography (silica
gel, CHCl3/MeOH 0.5%) to afford the penta-p-bromobenzoate
8 as a colorless solid (18.5 mg, 89%): CD (CH3CN) 252 nm
(∆ꢀ -2.7), 246 (0), 236 (+10.2), 208 (+8.7), 200 (0), 198 (-0.2);
Ben zyl 2-Deoxy-3,4-isop r op ylid en e-L-fu cop yr a n osid e
(15). (i) A solution of the fucose derivative 13 (2.90 g, 9.85
mmol) in THF (20 mL) was added to a dispension of sodium
hydride (0.59 g, 80% dispersion, 19.7 mmol) in THF (10 mL).
Imidazole (20 mg) was added, and the mixture was stirred at
25 °C under nitrogen. After 30 min, carbon disulfide (4.5 mL,
75 mmol) was added and stirring continued (1 h). Methyl
iodide (1.5 mL, 24 mmol) was then added, and after a further
15 min of stirring, the reaction mixture was poured into water
(100 mL) and extracted with CH2Cl2 (3 × 100 mL). The
combined, dried (MgSO4) extracts were evaporated under
reduced pressure to give the crude xanthate 14 (3.72 g, 98%),
which was used directly in the next step.
(ii) The xanthate 14 (3.72 g, 9.69 mmol) was dissolved in
dioxane (40 mL), triethylamine (14.9 mL, 107 mmol), and 50%
aqueous hypophosphorous acid (5.0 mL, 48 mmol) under
nitrogen. A 1 mL aliquot of a solution of AIBN (0.79 g, 4.84
mmol, in 5 mL dioxane) was added, and the reaction mixture
was heated to reflux. Further 1 mL aliquots of AIBN solution
were added until the reaction was complete by TLC (2.5 h).
IR (film) νmax 1710, 1580, 1245, 1075, 1065, 1005, 745 cm-1
;
1H NMR (CDCl3) δ 1.36 (d, J ) 6.4 Hz, 3H), 2.75 (m, 2H), 5.45
(m, 1H), 5.50 (qd, J ) 6.4, 6.2 Hz, 1H), 5.63 (dd, J ) 6.2, 4.2
Hz, 1H), 6.13 (dd, J ) 7.8, 6.1 Hz, 1H), 7.25 (s, 1H), 7.32 (s,
1H), 7.44 (d, J ) 8.6 Hz, 2H), 7.47 (d, J ) 8.6 Hz, 2H), 7.49 (d,
J ) 8.6 Hz, 2H), 7.55 (d, J ) 8.6 Hz, 2H), 7.59 (d, J ) 8.6 Hz,
2H), 7.65 (d, J ) 8.6 Hz, 2H), 7.68 (s, 1H), 7.72 (d, J ) 8.6 Hz,
2H), 7.78 (d, J ) 8.6 Hz, 2H), 7.82 (d, J ) 8.6 Hz, 2H), 7.91 (d,
J ) 8.6 Hz, 2H); FABMS m/ z 1224.8 (MH+, 5%) 1024.8 (M+
-
C7H4BrO2, 77%); HRFABMS found 1224.8010 (MH+),
C48H34N2O12Br5 requires 1224.8029.
(R)- a n d (S)-MTP A Mosh er Ester s 9a a n d 9b . Samples
of alcohol 6 (ca. 1-2 mg) were acylated, separately, with (R)-
and (S)-MTPA in the presence of DCC and DMAP in CH2Cl2
(32) Searle, P. A.; Molinski, T. F. Tetrahedron 1994, 50, 9893-9908.